Cargando…
Cardiovascular risk of sitagliptin in ischemic stroke patients with type 2 diabetes and chronic kidney disease: A nationwide cohort study
Limited data are available about the cardiovascular (CV) safety and efficacy of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, in ischemic stroke patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). Ischemic stroke patients with T2DM and CKD were selected from th...
Autores principales: | Liang, Chung-Yu, Chen, Dong-Yi, Mao, Chun-Tai, Hsieh, I-Chang, Hung, Ming-Jui, Wang, Chao-Hung, Wen, Ming-Shien, Cherng, Wen-Jin, Chen, Tien-Hsing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314701/ https://www.ncbi.nlm.nih.gov/pubmed/30593182 http://dx.doi.org/10.1097/MD.0000000000013844 |
Ejemplares similares
-
Sitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study
por: Chen, Dong-Yi, et al.
Publicado: (2015) -
Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke
por: Chen, Dong‐Yi, et al.
Publicado: (2019) -
Cardiovascular Outcomes of Sitagliptin in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Population-Based Cohort Study in Taiwan
por: Wang, Szu-Heng, et al.
Publicado: (2015) -
Short- and Long-Term Major Cardiovascular Adverse Events in Carotid Artery Interventions: A Nationwide Population-Based Cohort Study in Taiwan
por: Tsai, Ming-Lung, et al.
Publicado: (2015) -
Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock
por: Mao, Chun-Tai, et al.
Publicado: (2019)